| Patient | Zelda Fitzgerald |
|---|---|
| Date of birth | 1996-07-24 |
| Identifiers | MRN HR-ET004-SYN; SSN (made up) 000-04-8712 |
| Document date | 2026-09-14 |
| Author | Margot Ellery, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit, with contraception. [S]
Ms. Fitzgerald is a 30-year-old dancer and writer, five weeks after her three-month review, who comes for her yearly preventive visit and to talk again about contraception. Her diagnosis was revised at the last visit to bipolar I disorder with psychotic features, now in full remission, on lithium and aripiprazole. She has had no manic, depressive, or psychotic symptoms since the spring. Her periods have been regular since July. She dances about three and a half hours a day, eats three meals and two snacks as she planned with the dietitian, and has gained a little weight, which she accepts. She sleeps eight hours. At the last visit she learned that lithium can affect a developing baby's heart and that valproate is avoided because of its risks in pregnancy; she does not want a pregnancy for at least two years and would like a long-acting method. She uses condoms with a new partner. Her PHQ-9 today is 3. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 30 |
| Mood and psychosis | No symptoms since the spring; lithium 300 mg twice daily and aripiprazole 10 mg daily |
| Periods | Regular since July |
| Dance and food | About three and a half hours a day; meals and snacks as planned |
| Pregnancy plans | None for at least two years; would like a long-acting method |
| Mood | PHQ-9 3; item 9 scored 0 |
Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Ellery. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Supported by her roommate, her dance class, and the coordinated specialty care team; writing every morning |
| Substance use | AUDIT-C 1; no drugs |
| Tobacco | Never smoked |
| Physical activity | Dance about three and a half hours a day, with one full rest day a week |
| Nutrition | Three meals and two snacks; calcium-rich foods daily; SCOFF 0 of 5 |
| Sleep | About eight hours at regular times |
| Sexual and reproductive health | One new partner; condoms; no pregnancy wanted for at least two years |
| Safety at home | Feels safe; no one hurts, threatens, or controls her; no firearm in the home |
| Road safety | Wears a seat belt |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or fatigue; weight up a little as planned |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No dry mouth or sore throat |
| Cardiovascular | Negative | No chest pain, palpitations, or fainting |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea or diarrhea |
| Genitourinary | Negative | Regular periods; no increased thirst or urination; no discharge or pelvic pain |
| Endocrine | Negative | No heat or cold intolerance; no breast discharge |
| Musculoskeletal | Negative | No stress pain in the feet or shins |
| Integumentary | Negative | No acne flare or rash on lithium |
| Neurological | Negative | Faint fine tremor only when tired; no restlessness or stiffness |
| Psychiatric | Negative | Mood steady; PHQ-9 score 3; no racing thoughts, voices, or thoughts of suicide or self-harm |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital) | One tablet by mouth at bedtime | Oral route | 2026-04-20 to 2026-06-08 | completed | S |
| Lithium carbonate 300 mg oral capsule, one capsule by mouth twice daily | One capsule by mouth twice daily | Oral route | 2026-05-18 | active | S |
| Risperidone 1 mg oral tablet, one tablet by mouth at bedtime for one week, then stop | One tablet by mouth at bedtime for one week | Oral route | 2026-06-08 to 2026-06-15 | completed | S |
| Aripiprazole 10 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-06-08 | active | S |
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-09-14 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-14 | Body height | 165 | cm | S |
| 2026-09-14 | Body weight | 51.9 | kg | S |
| 2026-09-14 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 2026-09-14 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-09-14 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-09-14 | Heart rate | 68 | /min | S |
| 2026-09-14 | Respiratory rate | 14 | /min | S |
| 2026-09-14 | Body temperature | 36.6 | Cel | S |
| 2026-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-09-14 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 51.9 kg, BMI 19.1; blood pressure 108/68 |
| Neck | Thyroid not enlarged; no nodules |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender |
| Pelvic | Normal external genitalia, vagina, and cervix; uterus normal in size and position; no adnexal tenderness. HPV test collected; levonorgestrel intrauterine system placed without difficulty after a negative urine pregnancy test; strings trimmed to 3 cm |
| Skin | No rash or acne |
| Neurological | Very faint fine postural tremor; no rigidity or abnormal movements |
| Psychiatric | Bright, organized, and engaged; no psychotic or manic features |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| First episode of psychosis with marked mood symptoms: about three weeks of little sleep, rapid speech, racing thoughts, grandiose plans and very long training days, then a voice commenting on her dancing and a belief that she was being watched and tested; tearful low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, schizoaffective disorder (bipolar type), and schizophreniform disorder or schizophrenia, depending on whether the psychosis ever occurred apart from the mood symptoms. Synthetic modern episode linked to her documented first hospitalization | resolved | provisional | F29 | S — Synthetic modern coding of the documented first breakdown. Unspecified psychosis is coded until the course shows how the psychosis relates to the mood symptoms; superseded at the three-month visit. |
| Bipolar I disorder, most recent episode manic with psychotic features, in full remission: the working diagnosis at three months, when her history, her journal, and her roommate's account (given with her consent) showed that the voice and the belief she was watched began only after weeks of manic symptoms and ended with them, with no psychosis since. Remains provisional: it would be revised to schizoaffective disorder if psychosis ever lasted two weeks or more without a mood episode. Synthetic modern episode linked to the documented breakdown and its retrospective interpretations | active | provisional | F31.74 | S — Synthetic modern diagnosis made from the course; the historical diagnoses stay in the claims. |
| Secondary amenorrhea: no periods for about four months before admission, during very heavy dance training at a low weight (BMI 18.7), with prolactin raised on risperidone; pregnancy test negative | resolved | confirmed | N91.1 | S — Synthetic presenting finding linked to her documented training; resolved when her periods returned. |
| Acute viral gastroenteritis (vomiting and watery diarrhea for two days, roommate with the same illness), with mild dehydration; resolved | resolved | confirmed | A08.4 | S — Synthetic acute infection; not a historical claim. |
| Lithium level above the therapeutic range (1.4 mmol/L) during dehydration, with nausea and a worse fine tremor, without confusion or unsteadiness; lithium held and restarted; resolved | resolved | confirmed | T43.595A | S — Synthetic medication adverse effect at a prescribed dose; ICD-10-CM classifies lithium salts with the other antipsychotics and neuroleptics. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 108/68 mmHg |
| Depression screening | Completed today | PHQ-9 score 3, from 11 at intake; item 9 scored 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Eating and exercise screen | Completed today | SCOFF 0 of 5, from 1 at intake; regular periods; dancing about three and a half hours a day with a rest day; BMI 19.1 |
| Cervical cancer screening | Ordered | Last cytology three years ago was normal; primary HPV test collected today, every five years if negative |
| Contraception and pregnancy planning | Completed today | Levonorgestrel intrauterine system placed today; counseled that lithium carries a small added risk of heart defects early in pregnancy, that valproate is avoided because of birth defects and effects on a child's development, and to plan any pregnancy with psychiatry |
| Folic acid | Completed today | 0.4 mg daily started for a person who could become pregnant |
| Intimate partner violence screening | Completed today | Negative; she feels safe |
| HIV and hepatitis C screening | Ordered | No result on record; once-in-a-lifetime tests drawn today with her agreement |
| Chlamydia and gonorrhea screening | Ordered | Offered because of a new partner; urine test today |
| Diabetes and cholesterol screening | Up to date | Not due by age; fasting glucose 86 mg/dL, A1c 5.1% and lipids normal at the 12-week antipsychotic check; yearly while on aripiprazole |
| Influenza vaccine | Completed today | Given today |
| COVID-19 vaccine | Declined | Discussed; she prefers to wait and will reconsider in the winter |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap six years ago |
| HPV vaccine | Up to date | Series completed in adolescence |
Immunizations given today: Influenza vaccine, 2026-2027 season [S]
Guideline basis: U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)
Follow-up: HPV, HIV, hepatitis C, and sexual-health results by phone. Six-month review in six weeks with lithium level, creatinine, TSH, and the AIMS. Next preventive visit in one year. Next scheduled visit 2026-10-26: six-month review: maintenance treatment, lithium monitoring, and movement check. [S]
Voluntary advance care planning discussion of about 18 minutes, with her consent. She chose to complete a psychiatric advance directive: if she becomes ill again, she wants her early warning signs (sleeping less, training for hours, racing thoughts) taken seriously at once, to continue lithium, to avoid valproate, to be treated near home, and to have paper and pencils so she can write. She named a health care agent, recorded in the confidential part of the chart and not named here. She chose not to record other treatment preferences today. The directive will be revisited yearly or after any episode. [S]